Article info

Download PDFPDF
Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies
  1. Correspondence to:
 Dr A Bertolotto
 Centro Riferimento Regionale Sclerosi Multipla (CReSM) and Neurobiologia Clinica, ASO S. Luigi Gonzaga, Regione Gonzole 10, 10043, Orbassano, Torino, Italy; sclerosi.multiplasanluigi.piemonte.it
View Full Text

Citation

Bertolotto A, Sala A, Malucchi S, et al
Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies

Publication history

  • Received January 20, 2004
  • Accepted May 14, 2004
  • Revised April 21, 2004
  • First published August 16, 2004.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.